Clinical notes
Rheumatology Consult Note Template: Joints, Serology, and Plan
A rheumatology consult note lives in the pattern: which joints, what timing, inflammatory or mechanical, and what the serology actually says. This template follows Scribeberry's built-in Rheumatology Consult, used by clinicians for arthritis, connective tissue disease, and vasculitis referrals.
Rheumatology Consult Note Template: Joints, Serology, and Plan
Ready to review- Visit details pulled in
- Letter drafted from the conversation
- Your review and signature
Key takeaways
- A rheumatology consult note separates inflammatory from mechanical disease with pattern, stiffness timing, and joint counts.
- DMARD initiation requires documented baseline screening, vaccination, counselling, and a monitoring schedule.
- A recorded disease-activity score at every visit is what makes treat-to-target defensible.
What is a rheumatology consult note?
A rheumatology consult note is a written document that records a specialist assessment of musculoskeletal and autoimmune disease: the history of present rheumatologic symptoms, a rheumatologic examination with joint counts, laboratory and imaging results, a rheumatologic diagnosis, and a treatment plan covering medication management and therapy referrals. A rheumatology consult template keeps the inflammatory-versus-mechanical reasoning explicit, so the referring clinician can see why a DMARD was — or was not — started.
The template below matches Scribeberry's built-in Rheumatology Consult, one of the most-used specialty templates in Scribeberry. Unprovided results are marked Not Provided rather than assumed — in rheumatology, an invented serology is a dangerous fiction.
Blank rheumatology consult note template
Copy this structure into your EMR, or use it as the Rheumatology Consult inside Scribeberry, where it fills in from the encounter itself.
Rheumatology consult note
Chief Complaint (CC) History of Present Rheumatologic Symptoms (HPRS) Past Medical History (PMH) Medications Allergies Social History Family History Review of Systems (ROS) Rheumatologic Examination Laboratory Results Imaging Studies Diagnostic Procedures Rheumatologic Diagnosis Treatment Plan Medication Management Physical and Occupational Therapy Recommendations Prognosis Follow-up Plan Patient Education Consultation Recommendations (if applicable) Referral Recommendations (if applicable)
Example 1: New inflammatory arthritis
Rheumatology consult example — symmetric small-joint arthritis
Fictional example for illustration only. 47-year-old with 4 months of hand and foot pain and morning stiffness.
Chief complaint: Painful, stiff hands and feet. History of present rheumatologic symptoms: Four months of symmetric pain and swelling in MCPs, PIPs, wrists, and MTPs. Morning stiffness 2 hours, improves with activity, worsens with rest. Fatigue. No rash, photosensitivity, oral ulcers, Raynaud, or sicca. No preceding infection. Ibuprofen partially effective. Past medical history: Hypothyroidism. Family history: mother with rheumatoid arthritis. Social: non-smoker, works as a dental hygienist — grip function essential. Rheumatologic examination: Tender joint count 14, swollen joint count 9 (MCP 2–3 bilaterally, PIPs, wrists, MTPs). No dactylitis, enthesitis, or extra-articular signs. Grip strength reduced bilaterally. Laboratory results: CRP 38, ESR 52. RF positive 128 IU/mL, anti-CCP strongly positive >250. ANA negative. CBC, creatinine, LFTs normal. Imaging: Hand/foot radiographs — periarticular osteopenia, no erosions yet. Rheumatologic diagnosis: Rheumatoid arthritis, seropositive, early, moderate-high activity (DAS28 elevated). Treatment plan / medication management: Start methotrexate 15 mg weekly with folic acid, bridging prednisone taper, NSAID as needed. Baseline screening (CXR, hepatitis/TB serology) ordered; vaccination review; contraception counselling documented. Education: early treatment rationale, methotrexate monitoring and alcohol guidance, treat-to-target explained. PT/OT: hand OT referral for splinting and joint protection. Prognosis: Good with early therapy. Follow-up: 4 weeks with labs, then q4–6 weeks until low activity; DAS28 recorded each visit.
Example 2: Gout with escalating flares
Second example — recurrent gout and urate lowering
Fictional example for illustration only. 61-year-old with five gout flares in a year and a first-toe tophus.
Chief complaint: Repeated gout attacks. HPRS: Five flares in 12 months, first MTP and midfoot, each 5–7 days, treated with naproxen. Firm nodule over right first MTP, slowly enlarging. Drinks 2 beers daily. Recent start of hydrochlorothiazide for hypertension. Examination: Tophus right first MTP, no active synovitis today. BP 142/86. Laboratory: Urate 540 µmol/L, eGFR 58, HbA1c 6.1%. Imaging: Ultrasound double-contour sign at first MTP. Diagnosis: Chronic gout with tophus, frequent flares; contributing factors: thiazide, alcohol, CKD stage 3a. Medication management: Start allopurinol 100 mg daily (renally dosed) with colchicine prophylaxis ×3–6 months; titrate to urate <360 µmol/L (<300 given tophus). Liaise with primary care re thiazide alternative. Education: treat-to-target explained, flare action plan, alcohol reduction, do not stop allopurinol during flares. Follow-up: 4 weeks for urate and tolerance, then titration visits.
How to write a rheumatology consult note, step by step
- Pattern first: which joints, symmetric or not, small vs large, axial involvement.
- Time the stiffness: inflammatory stiffness lasts >30–60 minutes and eases with activity; mechanical pain does the opposite.
- Screen the systems connective tissue disease touches: rash, ulcers, Raynaud, sicca, serositis, cytopenias.
- Examine and count: tender and swollen joint counts, enthesitis, dactylitis, extra-articular signs.
- Put labs in their own section with dates — CRP/ESR, RF, anti-CCP, ANA and what they were ordered to answer.
- State the diagnosis and activity measure (e.g., DAS28) so response is auditable.
- Write medication management explicitly: drug, dose, monitoring, baseline screening, vaccination, and counselling.
- Close with therapy referrals, prognosis, patient education, and a follow-up interval tied to titration.
Inflammatory vs mechanical pain: the discriminating features
| Feature | Inflammatory | Mechanical / degenerative |
|---|---|---|
| Morning stiffness | >30–60 minutes | <30 minutes |
| Effect of activity | Improves with movement | Worsens with use |
| Effect of rest | Worsens | Improves |
| Night pain | Second-half-of-night pain common | Uncommon |
| Swelling | Soft tissue / synovial | Bony enlargement |
| Systemic features | Fatigue, elevated CRP/ESR | Usually absent |
Who uses a rheumatology consult note, and when
Rheumatologists and internists write rheumatology consult notes in specialty clinics and inpatient consultation; primary-care clinicians use the structure for suspected inflammatory disease referrals.
- New inflammatory arthritis and connective-tissue-disease referrals.
- DMARD initiation and treat-to-target follow-up.
- Crystal arthritis with recurrent flares or tophi.
- Vasculitis and systemic autoimmune assessments.
- Inpatient consultations for multisystem presentations.
Documentation, privacy, and record-keeping in Canada
Rheumatology notes justify high-stakes therapy: immunosuppressants with infection, malignancy, and teratogenicity considerations. Record baseline screening, vaccination status, pregnancy counselling where relevant, the monitoring schedule, and the disease-activity measure that will judge response. Canadian product monographs and specialty guidance set these expectations; the note is where a reviewer — or a court — checks that they were met before the first dose.
Across Canada, clinical notes form part of the legal medical record. Provincial regulators expect entries that are contemporaneous, factual, and attributable; health information is handled under provincial privacy law (such as PHIPA in Ontario, the HIA in Alberta, and Law 25 in Quebec) and PIPEDA where it applies. Disclose the minimum necessary, with patient consent, and record amendments as amendments — never by overwriting the original entry.
Common mistakes that weaken a rheumatology consult note
- Joint pain described with no pattern (which joints, symmetry, timing).
- Morning stiffness duration never asked or recorded.
- Serology listed with no statement of what it was ordered to answer.
- DMARD started with no baseline labs, screening, or monitoring interval.
- No disease-activity score, so response at follow-up cannot be judged.
- Patient education ('risks discussed') with no specifics documented.
The signing checklist
Before signing: Is the reason for the encounter explicit? Are negatives that change management recorded? Does every diagnosis have a plan with an owner and a date? Are results, counselling, and follow-up documented — or only intended?
Using this template in Scribeberry
Joint counts and serology, in their places
Choose Rheumatology Consult in Scribeberry and the examination, labs, and medication plan land in dedicated sections, drafted from the visit. Then Smart Push the note into your EMR and keep clinic on time.
Frequently asked questions
What should a rheumatology consult note include?
History of present rheumatologic symptoms with pattern and stiffness timing, a rheumatologic examination with joint counts, laboratory and imaging sections, the rheumatologic diagnosis with activity, a treatment plan with explicit medication management and monitoring, therapy referrals, education, and follow-up.
How do you tell inflammatory from mechanical pain in the note?
Document the discriminators: morning stiffness duration (>30–60 minutes suggests inflammatory), improvement with activity and worsening with rest, night pain in the second half of the night, synovial swelling, and systemic features with inflammatory markers.
What should be documented before starting a DMARD?
Baseline CBC, creatinine, and LFTs; infection screening (hepatitis, TB) where indicated; vaccination status; pregnancy/contraception counselling for teratogenic agents; and the monitoring schedule — all in the medication management section.
Can Scribeberry generate this note automatically?
Yes. The built-in Rheumatology Consult template follows this exact structure and drafts it from the recorded or dictated encounter, marking missing information as Not Provided instead of inventing it.
What must be documented before starting a DMARD?
Baseline CBC, creatinine and liver enzymes, infection screening as indicated, vaccination review, pregnancy/contraception counselling for teratogenic drugs, and the lab-monitoring schedule.
Why record a disease-activity score?
Treat-to-target care is auditable only if activity (for example DAS28 in rheumatoid arthritis) is measured at baseline and each follow-up and tied to escalation decisions.
References
- Good practices in medical record keeping — Canadian Medical Protective Association (CMPA)
- Medical Records Documentation — practice standard — College of Physicians and Surgeons of Ontario (CPSO)
- Personal Health Information Protection Act (PHIPA) — Government of Ontario
- Clinical resources and guidelines — Canadian Rheumatology Association
- Arthritis Society Canada — Arthritis Society Canada
Examples on this page are fictional and for illustration only; they do not describe real patients. Templates reflect the corresponding built-in template in Scribeberry at the date above.
